Search results for "Survival"

showing 10 items of 3291 documents

Pooled analysis of who surgical safety checklist use and mortality after emergency laparotomy

2019

Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not been assessed on a global scale. The aim of this study was to evaluate reported checklist use in emergency settings and examine the relationship with perioperative mortality in patients who had emergency laparotomy. Methods In two multinational cohort studies, adults undergoing emergency laparotomy were compared with those having elective gastrointestinal surgery. Relationships between reported checklist use and mortality were determined using multivariable logistic regression and bootstrapped simulation. Results Of 12 296 patients incl…

AdultMalebarriershumanoschecklist; surgery; human development indexGlobalSurg CollaborativeWHO Surgical Safety Checklist mortality emergency laparotomyWorld Health Organizationseguridad del pacienteNOCohort Studieslista de controlestudios prospectivosHumanstasa de supervivenciaProspective Studiesimplementationestudios de cohortesSurgery; implementation; health; barriersEmergency Treatment11 Medical and Health Sciencesmediana edadDigestive System Surgical ProceduresAgedancianoLaparotomyScience & TechnologyhealthOriginal ArticlesadultoMiddle Agedchecklist WHOprocedimientos quirúrgicos del sistema digestivoChecklistSurvival RateElective Surgical Procedureslaparotomíatratamiento de urgenciaSurgeryOriginal ArticleFemalePatient SafetyLife Sciences & Biomedicine
researchProduct

God, Faith, and Death: The Impact of Biological and Religious Correlates on Mortality

2004

Marked denominational mortality differentials have been documented for various time periods and geographic locations. From a historical perspective, death rates among Catholics are often found to be higher than those among Protestants or Jews. Using a conceptual model based on the life history approach, biomedical and sociocultural factors of causation are extrapolated. In total, 5513 historical entries from family reconstitution were available. Selection of data was guided by the inclusion of information about religious affiliation. Only married couples with children as well as single mothers were considered. Of these, 1855 entries were of Roman Catholic (C), 1143 of Lutheran/Protestant (L…

AdultMalemedia_common.quotation_subjectLongevityReligiosityFaithSex FactorsProtestantismPregnancyRisk FactorsGermanyInfant MortalityGeneticsHumansSociologyMortalityCausationChildSociocultural evolutionGenetics (clinical)Ecology Evolution Behavior and Systematicsmedia_commonMortality rateCatholicismInfant NewbornPregnancy OutcomeHistorical demographySingle mothersSurvival AnalysishumanitiesPedigreeParityMaternal MortalityProtestantismSocioeconomic FactorsFemaleDemographyHuman Biology
researchProduct

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.

2004

The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis is unclear. In a retrospective multicenter study, we have analyzed the virological events observed during lamivudine therapy in patients with HBeAg-negative chronic hepatitis and evaluated the correlation between virological response and clinical outcomes. Among 656 patients (mean age 49.1 years) included in the database, 54% had chronic hepatitis, 30% had Child-Turcotte-Pugh (CTP) A cirrhosis, and 16% had CTP B/C cirrhosis. On therapy (median 22 months, range 1–66), a virological response was obtained in 616 patients (93.9%). The rate of maintained virological respons…

AdultMalemedicine.medical_specialtyANTIVIRAL TREATMENTHepatitis B virusCirrhosisCarcinoma Hepatocellularmedicine.medical_treatmentEpatite cronica da Virus B trattamento antiviraleLAMIVUDINE; ANTIVIRAL TREATMENT; CHRONIC HEPATITIS B; TREATMENT RESISTANCECHRONIC HEPATITIS BLiver transplantationGastroenterologyLiver diseaseHepatitis B ChronicInternal medicineMedicineHumansHepatitis B e AntigensAgedRetrospective StudiesHepatologybusiness.industryIncidenceLiver NeoplasmsTREATMENT RESISTANCELamivudineHepatologyMiddle Agedmedicine.diseaseSurgeryLiver TransplantationSurvival RateTreatment OutcomeHBeAgLamivudineHepatocellular carcinomaMultivariate AnalysisMutationReverse Transcriptase InhibitorsFemalebusinessViral loadmedicine.drugHepatology (Baltimore, Md.)
researchProduct

Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course

2005

Abstract Purpose Hereditary angioedema (HAE) due to C1 inhibitor deficiency is clinically characterized by relapsing skin swellings, abdominal pain attacks, and life-threatening upper airway obstruction. Our aim was to examine a temporal and spatial pattern of the edema episodes by evaluating the long-term course of hereditary angioedema in order to establish a specific swelling pattern. Subjects and methods Data were generated from 221 patients with C1 inhibitor deficiency by asking them about symptoms they experienced during their edema episodes. Documentation was accomplished through the use of standardized questionnaires. Results A total of 131110 edema episodes were observed. Clinical …

AdultMalemedicine.medical_specialtyAbdominal painAdolescentLate onsetComplement C1 Inactivator ProteinsLaryngeal EdemaSeverity of Illness IndexDisease-Free SurvivalEcallantideEdemamedicineHumansAngioedemaChildSerpinsRetrospective StudiesAngioedemabusiness.industryGeneral MedicineMiddle AgedAirway obstructionmedicine.diseaseDermatologySurgeryHereditary angioedemaFemalemedicine.symptombusinessComplement C1 Inhibitor Proteinmedicine.drugThe American Journal of Medicine
researchProduct

Epidemiology and treatment of adenoid cystic carcinoma of the minor salivary glands: a meta-analytic study.

2010

OBJECTIVES: To evaluate the epidemiological aspects of adenoid cystic carcinoma (ACC) and to evaluate the different therapeutic possibilities as well as the percentage of survival. STUDY DESIGN: A retrospective, meta-analytic, observational study was carried out by selecting a total of 13 articles, which provided a sample size of 263 cases of patients who had been diagnosed with ACC in the minor salivary glands. RESULTS: ACC was found to be more common among women (56.5%) and the average age at diagnosis was 55.26 years old. The primary location of the tumor was in the palate in 57% of the cases, the predominant pattern being cribiform. The treatment of choice was therapy combined with surg…

AdultMalemedicine.medical_specialtyAdolescentAdenoid cystic carcinomamedicine.medical_treatmentSalivary Gland Neoplasms/Epidemiology/TherapySalivary Glands MinorTratamiento médicoYoung AdultInternal medicineEpidemiologymedicineCarcinomaEpidemiologíaHumansCarcinoma Adenoid Cystic/Epidemiology/TherapyYoung adultGeneral DentistrySurvival rateAgedRetrospective StudiesAged 80 and overbusiness.industryRetrospective cohort studyCáncerMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSalivary Gland NeoplasmsCarcinoma Adenoid CysticSurgeryRadiation therapySurvival Ratestomatognathic diseasesOtorhinolaryngologyMeta-analysisUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Use of Interferon-Alpha in Recurrent Respiratory Papillomatosis: 20-Year Follow-up

2005

Objectives: The aim of this study was analysis of the results of use of interferon-α (IFN-α) in patients with recurrent respiratory papillomatosis (RRP) and correlation of the results with human papillomavirus (HPV) type. Methods: A multicenter prospective series (42 patients from 22 hospitals) yielded 20 years of follow-up of patients with RRP and HPV typing who were treated with IFN-α in doses of 3 MU/m2 3 times per week. Results: During long-term follow-up (mean ± SD, 172 ± 36.8 months), the rate of event-free survival evaluated by Kaplan-Meier analysis was 42.8%, and the overall survival rate was 82.6%. The HPV typing revealed an association of HPV 11 with a more aggressive disease cour…

AdultMalemedicine.medical_specialtyAdolescentAlpha interferonAntineoplastic AgentsInjections IntramuscularDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdjuvant therapyHumansDNA Probes HPVProspective StudiesHuman papillomavirusChild030223 otorhinolaryngologyProspective cohort studyLaryngeal NeoplasmsPapillomaviridaeInterferon alfaPapillomabusiness.industryIncidence (epidemiology)InfantInterferon-alphaGeneral MedicineMiddle AgedSurgeryClinical trialTreatment OutcomeOtorhinolaryngologyChild Preschool030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalRecurrent Respiratory PapillomatosisbusinessFollow-Up Studiesmedicine.drugAnnals of Otology, Rhinology & Laryngology
researchProduct

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania

2008

Background Studies of antiretroviral therapy (ART) programs in Africa have shown high initial mortality. Factors contributing to this high mortality are poorly described. The aim of the present study was to assess mortality and to identify predictors of mortality in HIV-infected patients starting ART in a rural hospital in Tanzania. Methods This was a cohort study of 320 treatment-naïve adults who started ART between October 2003 and November 2006. Reliable CD4 cell counts were not available, thus ART initiation was based on clinical criteria in accordance with WHO and Tanzanian guidelines. Kaplan-Meier models were used to estimate mortality and Cox proportional hazards models to identify p…

AdultMalemedicine.medical_specialtyAdolescentAnemiaHospitals RuralHIV InfectionsKaplan-Meier EstimateTanzanialcsh:Infectious and parasitic diseasesCohort StudiesRisk FactorsInternal medicinemedicineHumanslcsh:RC109-216Survival analysis:Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801 [VDP]SurveillanceProportional hazards modelbusiness.industryHazard ratioMalnutritionAnemiaMiddle Agedmedicine.diseasePrognosisSurvival AnalysisThrombocytopenia:Medisinske Fag: 700::Helsefag: 800::Forebyggende medisin: 804 [VDP]SurgeryMalnutritionInfectious DiseasesAnti-Retroviral AgentsFemalebusinessRisk assessmentBody mass indexCohort studyFollow-Up StudiesResearch ArticleBMC Infectious Diseases
researchProduct

PROSAIKA: A prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting

2015

Abstract Objective Cerebrospinal fluid (CSF) overdrainage is a major problem in shunt therapy for hydrocephalus. The adjustable gravitational valve proSA allows for the first time a targeted compensation for overdrainage in the upright position without interfering with the differential pressure valve. To evaluate benefit, safety and reliability, the multicenter prospective registry PROSAIKA was conducted in 10 German neurosurgical centers. Methods Between March 2009 and July 2010, 120 hydrocephalic patients undergoing first time shunt implantation or shunt revision using proSA entered the study. 93 patients completed the 12 months follow-up. Results Hydrocephalus symptoms were improved in 8…

AdultMalemedicine.medical_specialtyAdolescentDifferential pressureVentriculoperitoneal ShuntYoung Adult03 medical and health sciences0302 clinical medicineClinical reportCerebrospinal fluidmedicineHumansProspective StudiesRegistriesChildSurvival rateAgedAged 80 and overbusiness.industryInfantEquipment DesignGeneral MedicineMiddle Agedmedicine.diseaseShunt surgeryCerebrospinal Fluid Shunts3. Good healthHydrocephalusSurgeryShuntingChild Preschool030220 oncology & carcinogenesisEquipment FailureFemaleSurgeryNeurology (clinical)business030217 neurology & neurosurgeryShunt (electrical)Follow-Up StudiesGravitationHydrocephalusClinical Neurology and Neurosurgery
researchProduct

Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and h…

2000

Intensive chemotherapy followed by treatment with interleukin-2 (IL-2) was evaluated in a prospective, randomized, multicenter trial including 18 patients with refractory anemia with excess of blasts in transformation (RAEB-T), 86 patients with acute myeloid leukemia (AML) evolving from myelodysplastic syndromes, and six patients with secondary AML after previous chemotherapy. Median age was 58 years (range: 18-76 years). Forty-nine patients (45%) achieved a complete remission (CR) after two induction cycles with idarubicin, ara-C, and etoposide, 52% of them aged/=60 years and 35% aged60 years (p=0.06). After two consolidation courses, patients were randomized to four cycles of either high-…

AdultMalemedicine.medical_specialtyAdolescentGastroenterologyInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineIdarubicinProspective StudiesSurvival rateEtoposideAgedEtoposideDose-Response Relationship Drugbusiness.industryMyelodysplastic syndromesCytarabineHematologyGeneral MedicineMiddle Agedmedicine.diseaseSurgerySurvival RateLeukemiaLeukemia MyeloidMyelodysplastic SyndromesAcute DiseaseCytarabineInterleukin-2FemaleImmunotherapyIdarubicinbusinessRefractory anemia with excess of blastsmedicine.drugAnnals of Hematology
researchProduct

Autologous fat transfer to the cranio-maxillofacial region: updates and controversies.

2009

Abstract Background Autologous fat grafts have gained popularity among Cranio-Maxillofacial surgeons within the past years. Most publications report favourable outcomes but lack quantifiable evidence of graft survival. Objectives To assess autologous fat transfer for facial asymmetry, and review the literature focusing on current indications, techniques, complications, fat survival and patient satisfaction. Patients and methods Nine patients presented facial asymmetry due to onchological resection, congenital anomaly, or craniofacial traumatism. A total of 11 autologous fat transfers were performed. Four procedures followed the Coleman technique; in the other seven procedures, fat centrifug…

AdultMalemedicine.medical_specialtyAdolescentInjections SubcutaneousAdipose tissueCentrifugationCosmetic TechniquesSuctionAutologous Fat Transferchemistry.chemical_compoundPatient satisfactionPostoperative ComplicationsAdipocytemedicineHumansCraniofacialbusiness.industryAbdominal WallGraft SurvivalMiddle AgedSurgeryCosmetic TechniquesOtorhinolaryngologychemistryAdipose TissueFacial AsymmetryPatient SatisfactionFaceTissue and Organ HarvestingSurgeryGraft survivalFemaleOral SurgerybusinessFacial symmetryJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
researchProduct